Clinical Outcomes of Transcatheter Arterial Embolization for Adhesive Capsulitis Resistant to Conservative Treatment

Yuji Okuno, Wataru Iwamoto, Noboru Matsumura, Sota Oguro, Taku Yasumoto, Takao Kaneko, Hiroyasu Ikegami

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Purpose To evaluate clinical outcomes of transcatheter arterial embolization (TAE) for adhesive capsulitis resistant to conservative treatments. Materials and Methods This study comprised 25 patients (18 women and 7 men; mean age, 53.8 y; range, 39–68 y) with adhesive capsulitis resistant to conservative treatments. TAE was performed, and adverse events (AEs), pain visual analog scale (VAS) score changes, range of motion (ROM), and American Shoulder and Elbow Surgeons (ASES) scores were assessed. Results Abnormal vessels were identified in all patients. No major AEs were associated with TAE. One patient was lost to follow-up. The remaining 24 patients were available for final follow-up (mean, 36.1 months; range, 30–44 months). Of the 24 patients, 16 (67%) experienced quick improvement of nighttime pain (ie, VAS scores decreased > 50% from baseline) within 1 week, and 21 (87%) improved within 1 month. In terms of mean overall pain (ie, pain at its worst), VAS scores significantly decreased at 1, 3, and 6 months after treatment (82 mm before treatment vs 52, 19, and 8 mm after treatment; P < .001). ASES scores significantly improved at 1, 3, and 6 months after treatment (16.1 before treatment vs 41.4, 69.1, and 83.5 after treatment; P < .001). No symptom recurrence or late-onset AEs were observed. Shoulder ROM and function further improved during midterm follow-up. Conclusions TAE is a possible treatment option for patients with adhesive capsulitis that has failed to improve with conservative treatments.

Original languageEnglish
Pages (from-to)161-167.e1
JournalJournal of Vascular and Interventional Radiology
Volume28
Issue number2
DOIs
Publication statusPublished - 2017 Feb 1

Fingerprint

Bursitis
Pain Measurement
Elbow
Articular Range of Motion
Therapeutics
Pain
Lost to Follow-Up
Conservative Treatment
Visual Analog Scale
Recurrence

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Clinical Outcomes of Transcatheter Arterial Embolization for Adhesive Capsulitis Resistant to Conservative Treatment. / Okuno, Yuji; Iwamoto, Wataru; Matsumura, Noboru; Oguro, Sota; Yasumoto, Taku; Kaneko, Takao; Ikegami, Hiroyasu.

In: Journal of Vascular and Interventional Radiology, Vol. 28, No. 2, 01.02.2017, p. 161-167.e1.

Research output: Contribution to journalArticle

Okuno, Yuji ; Iwamoto, Wataru ; Matsumura, Noboru ; Oguro, Sota ; Yasumoto, Taku ; Kaneko, Takao ; Ikegami, Hiroyasu. / Clinical Outcomes of Transcatheter Arterial Embolization for Adhesive Capsulitis Resistant to Conservative Treatment. In: Journal of Vascular and Interventional Radiology. 2017 ; Vol. 28, No. 2. pp. 161-167.e1.
@article{fe7fdbcab5024b2092423a3c4799a8bf,
title = "Clinical Outcomes of Transcatheter Arterial Embolization for Adhesive Capsulitis Resistant to Conservative Treatment",
abstract = "Purpose To evaluate clinical outcomes of transcatheter arterial embolization (TAE) for adhesive capsulitis resistant to conservative treatments. Materials and Methods This study comprised 25 patients (18 women and 7 men; mean age, 53.8 y; range, 39–68 y) with adhesive capsulitis resistant to conservative treatments. TAE was performed, and adverse events (AEs), pain visual analog scale (VAS) score changes, range of motion (ROM), and American Shoulder and Elbow Surgeons (ASES) scores were assessed. Results Abnormal vessels were identified in all patients. No major AEs were associated with TAE. One patient was lost to follow-up. The remaining 24 patients were available for final follow-up (mean, 36.1 months; range, 30–44 months). Of the 24 patients, 16 (67{\%}) experienced quick improvement of nighttime pain (ie, VAS scores decreased > 50{\%} from baseline) within 1 week, and 21 (87{\%}) improved within 1 month. In terms of mean overall pain (ie, pain at its worst), VAS scores significantly decreased at 1, 3, and 6 months after treatment (82 mm before treatment vs 52, 19, and 8 mm after treatment; P < .001). ASES scores significantly improved at 1, 3, and 6 months after treatment (16.1 before treatment vs 41.4, 69.1, and 83.5 after treatment; P < .001). No symptom recurrence or late-onset AEs were observed. Shoulder ROM and function further improved during midterm follow-up. Conclusions TAE is a possible treatment option for patients with adhesive capsulitis that has failed to improve with conservative treatments.",
author = "Yuji Okuno and Wataru Iwamoto and Noboru Matsumura and Sota Oguro and Taku Yasumoto and Takao Kaneko and Hiroyasu Ikegami",
year = "2017",
month = "2",
day = "1",
doi = "10.1016/j.jvir.2016.09.028",
language = "English",
volume = "28",
pages = "161--167.e1",
journal = "Journal of Vascular and Interventional Radiology",
issn = "1051-0443",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Clinical Outcomes of Transcatheter Arterial Embolization for Adhesive Capsulitis Resistant to Conservative Treatment

AU - Okuno, Yuji

AU - Iwamoto, Wataru

AU - Matsumura, Noboru

AU - Oguro, Sota

AU - Yasumoto, Taku

AU - Kaneko, Takao

AU - Ikegami, Hiroyasu

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Purpose To evaluate clinical outcomes of transcatheter arterial embolization (TAE) for adhesive capsulitis resistant to conservative treatments. Materials and Methods This study comprised 25 patients (18 women and 7 men; mean age, 53.8 y; range, 39–68 y) with adhesive capsulitis resistant to conservative treatments. TAE was performed, and adverse events (AEs), pain visual analog scale (VAS) score changes, range of motion (ROM), and American Shoulder and Elbow Surgeons (ASES) scores were assessed. Results Abnormal vessels were identified in all patients. No major AEs were associated with TAE. One patient was lost to follow-up. The remaining 24 patients were available for final follow-up (mean, 36.1 months; range, 30–44 months). Of the 24 patients, 16 (67%) experienced quick improvement of nighttime pain (ie, VAS scores decreased > 50% from baseline) within 1 week, and 21 (87%) improved within 1 month. In terms of mean overall pain (ie, pain at its worst), VAS scores significantly decreased at 1, 3, and 6 months after treatment (82 mm before treatment vs 52, 19, and 8 mm after treatment; P < .001). ASES scores significantly improved at 1, 3, and 6 months after treatment (16.1 before treatment vs 41.4, 69.1, and 83.5 after treatment; P < .001). No symptom recurrence or late-onset AEs were observed. Shoulder ROM and function further improved during midterm follow-up. Conclusions TAE is a possible treatment option for patients with adhesive capsulitis that has failed to improve with conservative treatments.

AB - Purpose To evaluate clinical outcomes of transcatheter arterial embolization (TAE) for adhesive capsulitis resistant to conservative treatments. Materials and Methods This study comprised 25 patients (18 women and 7 men; mean age, 53.8 y; range, 39–68 y) with adhesive capsulitis resistant to conservative treatments. TAE was performed, and adverse events (AEs), pain visual analog scale (VAS) score changes, range of motion (ROM), and American Shoulder and Elbow Surgeons (ASES) scores were assessed. Results Abnormal vessels were identified in all patients. No major AEs were associated with TAE. One patient was lost to follow-up. The remaining 24 patients were available for final follow-up (mean, 36.1 months; range, 30–44 months). Of the 24 patients, 16 (67%) experienced quick improvement of nighttime pain (ie, VAS scores decreased > 50% from baseline) within 1 week, and 21 (87%) improved within 1 month. In terms of mean overall pain (ie, pain at its worst), VAS scores significantly decreased at 1, 3, and 6 months after treatment (82 mm before treatment vs 52, 19, and 8 mm after treatment; P < .001). ASES scores significantly improved at 1, 3, and 6 months after treatment (16.1 before treatment vs 41.4, 69.1, and 83.5 after treatment; P < .001). No symptom recurrence or late-onset AEs were observed. Shoulder ROM and function further improved during midterm follow-up. Conclusions TAE is a possible treatment option for patients with adhesive capsulitis that has failed to improve with conservative treatments.

UR - http://www.scopus.com/inward/record.url?scp=85008323978&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85008323978&partnerID=8YFLogxK

U2 - 10.1016/j.jvir.2016.09.028

DO - 10.1016/j.jvir.2016.09.028

M3 - Article

VL - 28

SP - 161-167.e1

JO - Journal of Vascular and Interventional Radiology

JF - Journal of Vascular and Interventional Radiology

SN - 1051-0443

IS - 2

ER -